全部树

China university patent statisticsNEW

China high-tech enterprise patent statisticsNEW

Digital economy patent application and authorization dataNEW

Patents and citation data of Little Giant and individual champion companiesNEW

Small giant and single champion enterprise design patent details table

Statistics on the entry and exit of Chinese industrial and commercial enterprisesNEW

Statistics on entry and exit information of Chinese partnershipsNEW

Basic information data of manufacturing industrial and commercial registered enterprisesNEW

Patent and citation data of A-share listed companiesNEW

Patent details of A-share listed companies
A-share listed companies' patent application details table
Details of Design Patents Authorized by A-share Listed Companies

Green patents and citation data of A-share listed companies

A-share listed companies green patent details table

Patent and citation data of Chinese industrial enterprisesNEW

Green patents and citation data of Chinese industrial enterprisesNEW

Details of Green Patents of Chinese Industrial Enterprises

Tax investigation of corporate patents and citation dataNEW

Cost of living data for global residentsNEW

China foreign trade index data

Introduction to Industrial and Commercial Registration Data of Nucleic Acid Testing Institutions

   Since the outbreak of COVID-19, nucleic acid testing has played a proactive role in early detection of positive cases based on practical experience from nationwide pandemic containment efforts, and has been vigorously promoted as a fundamental measure for regular epidemic prevention and control. Currently, specialized nucleic acid testing institutions have been established across China. According to regulations from the National Health Commission, there are three main types of healthcare institutions providing nucleic acid testing services in China: 1) medical institutions such as hospitals and maternal and child health centers; 2) disease control agencies, including centers at national, provincial, municipal, and county levels; and 3) medical testing laboratories, categorized as healthcare institutions and commonly referred to as "third-party testing institutions".

   By the end of 2022, health administrative departments in Lanzhou, Beijing, Hefei, Shijiazhuang, Xuchang, Inner Mongolia, and other regions discovered serious illegal activities involving falsified test reports by certain testing institutions, with particular societal scrutiny directed at third-party testing companies.

   Against this backdrop, CnOpenData has collected comprehensive industrial and commercial basic information, shareholder details, external investment records of shareholders, and registration change histories for all nucleic acid testing institutions based on the national registry, aiming to facilitate related research.


Time Coverage

As of July 31, 2023


Field Descriptions


Sample Data

This page displays partial tables due to the extensive dataset. For complete data, please view detailed sub-tables in the left navigation.

Basic Industrial and Commercial Data of Nucleic Acid Testing Institutions

Registered Capital Contribution Data of Nucleic Acid Testing Institutions

Shareholder Basic Data of Nucleic Acid Testing Institutions

Shareholders' External Investment Data of Nucleic Acid Testing Institutions

External Investment Data of Nucleic Acid Testing Institutions


Data Update Frequency

Annual updates